Targeted Strategies for Today's Evolving Markets

MissionIR Blog

OncoSec Medical, Inc. (ONCS) Starts Presentation at 4th Annual LD Micro Conference

Posted on June 4, 2014 by MissionIR

OncoSec Medical, Inc. (OTC: ONCS) designs and develops novel cancer therapeutic products. The company’s products combine proprietary delivery technology with a novel DNA-based immunotherapeutics, known as OMS ElectroOncology. OncoSec’s clinical programs include: the NeoPulse approach, which is in clinical trials for the treatment of recurrent head, neck and breast cancer; and three clinical trials assessing the cancer-destroying and tissue-sparing properties of the ImmunoPulse technology. For more information, visit the company’s website at www.oncosec.com.

The three-day LD Micro Invitational in Bel Air, California, features company presentations from more than 200 select high-potential small-cap companies spanning multiple industries. Institutional and retail investors in attendance also have access to numerous networking opportunities and social events to learn more about these companies. For more information on LD Micro, visit www.ldmicro.com
This entry was posted in LD Micro Conference. Bookmark the permalink.

Comments are closed.